Form 8-K - Current report:
SEC Accession No. 0001558370-25-009085
Filing Date
2025-07-03
Accepted
2025-07-03 16:10:15
Documents
13
Period of Report
2025-06-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250630x8k.htm   iXBRL 8-K 38794
  Complete submission text file 0001558370-25-009085.txt   160879

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20250630.xsd EX-101.SCH 4125
3 EX-101.DEF chrs-20250630_def.xml EX-101.DEF 3586
4 EX-101.LAB chrs-20250630_lab.xml EX-101.LAB 17204
5 EX-101.PRE chrs-20250630_pre.xml EX-101.PRE 11368
15 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250630x8k_htm.xml XML 4900
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251105645
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)